ISRG
Intuitive Surgical, Inc.
Intuitive Surgical, Inc. insider trading
Intuitive Surgical, Inc. files with the SEC as a Orthopedic, Prosthetic & Surgical Appliances & Supplies company headquartered in Sunnyvale, CA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent ISRG insider transactions
5 insiders traded ISRG on the open market between Jun 10, 2026 and Sep 15, 2026 — 24 sales worth $5.2M, of which every one was pre-scheduled under a 10b5-1 plan.
- Bought
- —
- Sold
- $5.2M
- Net
- −$5.2M
- Insiders
- 5
24 of 24 on a 10b5-1 plan
Widman Fredrik10b5-1
VP Corporate Controller
−$204.4K
Sep 15, 2026
546 sh · $374.44
Widman Fredrik10b5-1
VP Corporate Controller
−$203.3K
Sep 15, 2026
543 sh · $374.44
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.1K
Sep 11, 2026
25 sh · $365.79
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$8K
Sep 10, 2026
23 sh · $347.66
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$8.1K
Sep 09, 2026
23 sh · $350.20
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$16.6K
Sep 08, 2026
46 sh · $361.23
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$28.9K
Aug 21, 2026
77 sh · $375.57
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$30.5K
Aug 20, 2026
77 sh · $396.37
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$30.4K
Aug 19, 2026
77 sh · $394.26
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$30.3K
Aug 18, 2026
77 sh · $394.00
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$30.1K
Aug 17, 2026
77 sh · $390.67
Guthart Gary S10b5-1
Director
−$4M
Aug 11, 2026
10,000 sh · $400.00
Ladd Amy L10b5-1
Director
−$28.3K
Aug 11, 2026
72 sh · $393.10
Ladd Amy L10b5-1
Director
−$151.6K
Aug 10, 2026
400 sh · $379.00
Loeb Gary10b5-1
EVP & Chief Legal and Complian
−$151.6K
Aug 10, 2026
400 sh · $379.00
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.8K
Jul 31, 2026
28 sh · $351.00
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.7K
Jul 30, 2026
28 sh · $346.83
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$10.1K
Jul 29, 2026
28 sh · $360.21
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$10.2K
Jul 28, 2026
28 sh · $365.58
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.6K
Jul 27, 2026
28 sh · $344.00
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$10.4K
Jun 12, 2026
25 sh · $414.13
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.5K
Jun 11, 2026
23 sh · $412.16
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.8K
Jun 10, 2026
23 sh · $424.14
Loeb Gary10b5-1
EVP & Chief Legal and Complian
−$169.7K
Jun 10, 2026
400 sh · $424.14
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Widman Fredrik10b5-1VP Corporate Controller | 546 | $374.44 | −$204.4K |
| Sep 15, 2026 | Widman Fredrik10b5-1VP Corporate Controller | 543 | $374.44 | −$203.3K |
| Sep 11, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 25 | $365.79 | −$9.1K |
| Sep 10, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $347.66 | −$8K |
| Sep 09, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $350.20 | −$8.1K |
| Sep 08, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 46 | $361.23 | −$16.6K |
| Aug 21, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 77 | $375.57 | −$28.9K |
| Aug 20, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 77 | $396.37 | −$30.5K |
| Aug 19, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 77 | $394.26 | −$30.4K |
| Aug 18, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 77 | $394.00 | −$30.3K |
| Aug 17, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 77 | $390.67 | −$30.1K |
| Aug 11, 2026 | Guthart Gary S10b5-1Director | 10,000 | $400.00 | −$4M |
| Aug 11, 2026 | Ladd Amy L10b5-1Director | 72 | $393.10 | −$28.3K |
| Aug 10, 2026 | Ladd Amy L10b5-1Director | 400 | $379.00 | −$151.6K |
| Aug 10, 2026 | Loeb Gary10b5-1EVP & Chief Legal and Complian | 400 | $379.00 | −$151.6K |
| Jul 31, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 28 | $351.00 | −$9.8K |
| Jul 30, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 28 | $346.83 | −$9.7K |
| Jul 29, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 28 | $360.21 | −$10.1K |
| Jul 28, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 28 | $365.58 | −$10.2K |
| Jul 27, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 28 | $344.00 | −$9.6K |
| Jun 12, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 25 | $414.13 | −$10.4K |
| Jun 11, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $412.16 | −$9.5K |
| Jun 10, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $424.14 | −$9.8K |
| Jun 10, 2026 | Loeb Gary10b5-1EVP & Chief Legal and Complian | 400 | $424.14 | −$169.7K |
SEC Form 4 data, Q3 2024 to Q2 2026
ISRG insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 16 insiders traded ISRG on the open market: 0 purchases and 188 sales worth $227.1M, every sale pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 69 sales ($109.9M), by 12 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$3.1M15 sales · all on a plan | |
| Q1 2026 | — | −$21.3M21 sales · all on a plan | |
| Q4 2025 | — | −$63.8M26 sales · all on a plan | |
| Q3 2025 | — | −$21.7M7 sales · all on a plan | |
| Q2 2025 | — | −$10.1M23 sales · all on a plan | |
| Q1 2025 | — | −$33.6M36 sales · all on a plan | |
| Q4 2024 | — | −$36M29 sales · all on a plan | |
| Q3 2024 | — | −$37.5M31 sales · all on a plan |
- Largest sale
- −$15.8M of ISRG by Guthart Gary S (Executive Chair of the Board o · Director) on Oct 24, 2025, under a 10b5-1 plan.
Open-market transactions through Jun 30, 2026most recent first
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.7K
Jun 09, 2026
23 sh · $421.13
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$9.7K
Jun 08, 2026
23 sh · $420.12
Jeddi Iman10b5-1
SVP & GM da Vinci Platforms &
−$2.4M
Jun 01, 2026
5,625 sh · $420.55
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$7.9K
May 22, 2026
18 sh · $439.80
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$8K
May 21, 2026
18 sh · $446.04
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$7.9K
May 20, 2026
18 sh · $440.38
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$7.9K
May 19, 2026
18 sh · $440.70
Brosius Mark10b5-1
EVP & Chief Mfg and Supply Cha
−$7.6K
May 18, 2026
18 sh · $422.47
Loeb Gary10b5-1
EVP & Chief Legal and Complian
−$178.8K
May 11, 2026
400 sh · $446.95
Ladd Amy L10b5-1
Director
−$55.2K
Apr 29, 2026
119 sh · $463.50
Ladd Amy L10b5-1
Director
−$236.7K
Apr 28, 2026
500 sh · $473.46
Curet Myriam10b5-1
EVP & Chief Medical Officer
−$51.9K
Mar 10, 2026
105 sh · $493.95
Brosius Mark10b5-1
SVP & Chief Mfg and Supply Cha
−$312.8K
Mar 09, 2026
645 sh · $485.01
Brosius Mark10b5-1
SVP & Chief Mfg and Supply Cha
−$317.6K
Mar 06, 2026
648 sh · $490.19
Brosius Mark10b5-1
SVP & Chief Mfg and Supply Cha
−$320.9K
Mar 05, 2026
648 sh · $495.20
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 09, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $421.13 | −$9.7K |
| Jun 08, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 23 | $420.12 | −$9.7K |
| Jun 01, 2026 | Jeddi Iman10b5-1SVP & GM da Vinci Platforms & | 5,625 | $420.55 | −$2.4M |
| May 22, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 18 | $439.80 | −$7.9K |
| May 21, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 18 | $446.04 | −$8K |
| May 20, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 18 | $440.38 | −$7.9K |
| May 19, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 18 | $440.70 | −$7.9K |
| May 18, 2026 | Brosius Mark10b5-1EVP & Chief Mfg and Supply Cha | 18 | $422.47 | −$7.6K |
| May 11, 2026 | Loeb Gary10b5-1EVP & Chief Legal and Complian | 400 | $446.95 | −$178.8K |
| Apr 29, 2026 | Ladd Amy L10b5-1Director | 119 | $463.50 | −$55.2K |
| Apr 28, 2026 | Ladd Amy L10b5-1Director | 500 | $473.46 | −$236.7K |
| Mar 10, 2026 | Curet Myriam10b5-1EVP & Chief Medical Officer | 105 | $493.95 | −$51.9K |
| Mar 09, 2026 | Brosius Mark10b5-1SVP & Chief Mfg and Supply Cha | 645 | $485.01 | −$312.8K |
| Mar 06, 2026 | Brosius Mark10b5-1SVP & Chief Mfg and Supply Cha | 648 | $490.19 | −$317.6K |
| Mar 05, 2026 | Brosius Mark10b5-1SVP & Chief Mfg and Supply Cha | 648 | $495.20 | −$320.9K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Intuitive Surgical, Inc. company record
- SEC industry classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Sunnyvale, CA
- Incorporated in
- DE
- Listed on
- Nasdaq
- SEC Central Index Key
- 0001035267
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought ISRG
What the stock actually did in the 90 days following each open-market purchase
Don't check ISRG — let it ping you
Get told the moment an insider moves on ISRG
Pro watches Intuitive Surgical, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ISRG to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read ISRG insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are ISRG insiders buying or selling?
- Between Jun 10, 2026 and Sep 15, 2026, 5 Intuitive Surgical, Inc. insiders made no open-market purchases and 24 sales worth $5.2M, a net sale of $5.2M. 24 of the sales were pre-scheduled under a Rule 10b5-1 plan.
- How much ISRG stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 16 Intuitive Surgical, Inc. insiders made no open-market purchases and 188 sales worth $227.1M. Every one of the sales was pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 69 sales ($109.9M). The largest sale was Guthart Gary S selling $15.8M on Oct 24, 2025.
- What was the largest recent ISRG insider trade?
- Guthart Gary S (Director) sold $4M of ISRG stock on Aug 11, 2026 at about $400.00 a share, under a pre-scheduled 10b5-1 plan.
- When did an insider last buy ISRG shares?
- No open-market purchase by a Intuitive Surgical, Inc. insider appears in the filings from Jun 10, 2026 to Sep 15, 2026 — every recorded open-market transaction in that period was a sale.
- Where does ISRG insider trading data come from?
- From the Form 4 filings Intuitive Surgical, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.